http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
| This week's FierceLifeSci is brought to you by ExL Events. |
| Dear Colleague, As one of the chairs for the FierceBiotech Drug Development Forum (Oct. 1–3 in Boston), I invite you to join me at this fall event so that your company can benefit from the in-depth learning experiences available there. The agenda for this year has been built specifically around audience feedback in order to focus on the greatest challenges the industry is facing: both from a partnership and deal-making perspective, and also when devising strategies for preclinical and early clinical research. |
|
|
| In the track that I am chairing, our conversations will focus on: Improving relationships with VCs Guarding IP for generics and biologics Achieving higher value assets in specialty pharma Predicting and withstanding the next market downturn Clarifying whether to discover or buy new drug candidates |
|
|
| The more you can learn and network with industry leaders, the smoother your own product life cycle will become, so I hope you will join me in Boston this October. Register here today and use Discount Code FIERCE15 to save 15% off registration rates. Sincerely, Richard Brudnick
Chief Business Officer, Head of Strategy
Codiak Biosciences |
|
|
| For information on sponsorship and exhibition opportunities, please contact Andrew Sinetar at 212-400-6237 or [email protected]. |
|
|
|
| Want to reach 200,000+ FierceLifeSci subscribers with your own message?
Contact [email protected] or call 202-824-5074.
About this email: In order to receive FierceLifeSci for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceLifeSci.
Click here to unsubscribe. Refer to our Privacy Policy.
FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400
Washington, DC 20036 |
.
